Encompassing all Executive through Board Positions in Life Sciences

Director of the Board

Yes

Chief Executive Officer

Yes

Chief Business Officer

Leading publicly traded biopharmaceutical stem cell company.

No

Chairman of the Board

Yes

Chief Financial Officer

Formerly Aastrom Biosciences

Yes

Chief Operating Officer

Yes

Chief Scientific Officer

Leading publicly traded monoclonal antibody & oncology company

No

Executive Vice President, Orthopedics and Chief Operating Officer

Formerly BioMimetic Therapeutics, Inc.

Yes
See More

In The News

Bavarian Nordic signs ‘larger’ monkeypox vaccine supply deal with unnamed country aliu Wed, 05/25/2022 – 08:38

https://www.fiercepharma.com/pharma/bavarian-nordic-signs-larger-monkeypox-vaccine-supply-deal-mysterious-country

US to provide Bavarian Nordic’s vaccine Jynneos to some at risk for monkeypox, CDC says kdunleavy Tue, 05/24/2022 – 15:30

https://www.fiercepharma.com/pharma/us-will-provide-jynneos-vaccine-those-risk-monkeypox-cdc-says

The biotech plans to seek FDA approval for its soft-tissue tumor treatment after positive study results. But investors still sent the stock down by nearly 10%.

https://www.biopharmadive.com/news/springworks-desmoid-tumors-nirogacestat-trial-fda/624286/

The two companies are each developing new types of medicines that they hope can soon win FDA approval for treating the autoimmune disease.

https://www.biopharmadive.com/news/pfizer-eli-lilly-ulcerative-colitis-etrasimod-mirikizumab/624268/

One day after the U.S. began releasing supplies of an approved Bavarian Nordic shot, Moderna said it's beginning development of its own vaccine against the virus.

https://www.biopharmadive.com/news/moderna-monkeypox-vaccine-who-outbreak/624282/

With inhaled version of Tyvaso, United Therapeutics sniffs a potential blockbuster kdunleavy Tue, 05/24/2022 – 09:44

https://www.fiercepharma.com/pharma/inhaled-version-tyvaso-united-sniffs-potential-blockbuster

See More Events

Read More Articles